Comparison of disposition and effect of timolol and propranolol on exercise tachycardia
- PMID: 32043
- DOI: 10.1007/BF00560252
Comparison of disposition and effect of timolol and propranolol on exercise tachycardia
Abstract
The kinetic disposition and beta-adrenergic blocking action in relation to plasma level of a single oral dose of either timolol or propranolol has been compared in healthy male volunteers. The disposition profiles clearly disclosed different properties of the two drugs, although their half-lives were similar. The available fraction of timolol in the systemic circulation was estimated to be approximately 60% of the dose, and 17.4% was exereted unchanged in urine. The logarithm of plasma concentration showed a significant correlation with the beta-blocking activity assessed by an exercise test. The mean potency ratios of timolol to propranolol as an antagonist of chronotropic effects on exercise tachycardia were 11 to 17 and 3.6 to 5.5 in dose- and concentration-effect relationships, respectively. The absolute reduction of exercise heart rate gave the best coefficient of all measures of beta-blockade. When drug action was measured as beta-blockade assessed by a given response to exercise tachycardia, the effect declined linearly with time, even though plasma levels fell exponentially. This results suggest that the pharmacokinetic t1/2 is much shorter than the pharmacological t1/2.
Similar articles
-
Duration of cardiac effects of timolol and propranolol.Clin Pharmacol Ther. 1976 Feb;19(2):148-52. doi: 10.1002/cpt1976192148. Clin Pharmacol Ther. 1976. PMID: 4254 Clinical Trial.
-
Comparison of cardiac effects of timolol and propranolol.Clin Pharmacol Ther. 1975 Sep;18(3):278-86. doi: 10.1002/cpt1975183278. Clin Pharmacol Ther. 1975. PMID: 1100298 Clinical Trial.
-
Clinical pharmacologic observations on timolol. I. Disposition and effect in relation to plasma level in normal individuals.J Clin Pharmacol. 1978 Nov-Dec;18(11-12):511-8. doi: 10.1002/j.1552-4604.1978.tb01580.x. J Clin Pharmacol. 1978. PMID: 721948
-
Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).Br J Clin Pharmacol. 1979;7 Suppl 2(Suppl 2):167S-172S. doi: 10.1111/j.1365-2125.1979.tb04687.x. Br J Clin Pharmacol. 1979. PMID: 37871 Free PMC article. Clinical Trial.
-
Comparative review of beta-blocking agents.Conn Med. 1984 Apr;48(4):213-5. Conn Med. 1984. PMID: 6143648 Review. No abstract available.
Cited by
-
Concentration-effect and time-effect relationships of carteolol.Eur J Clin Pharmacol. 1983;25(6):749-57. doi: 10.1007/BF00542514. Eur J Clin Pharmacol. 1983. PMID: 6141053
-
The effect of propranolol on exercise induced tachycardia is determined by plasma concentration and the density of adrenergic receptors on leukocytes.Eur J Clin Pharmacol. 1987;31(6):667-72. doi: 10.1007/BF00541293. Eur J Clin Pharmacol. 1987. PMID: 3830254
-
A standard approach to compiling clinical pharmacokinetic data.J Pharmacokinet Biopharm. 1981 Feb;9(1):59-127. doi: 10.1007/BF01059343. J Pharmacokinet Biopharm. 1981. PMID: 7014827
-
A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.Br J Clin Pharmacol. 1983 Jul;16(1):17-25. doi: 10.1111/j.1365-2125.1983.tb02138.x. Br J Clin Pharmacol. 1983. PMID: 6349668 Free PMC article. Clinical Trial.
-
Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.Eur J Clin Pharmacol. 1985;29(2):131-47. doi: 10.1007/BF00547412. Eur J Clin Pharmacol. 1985. PMID: 3000793 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources